INNOVATION FOR LIFE
Diagenics Group SE is a biopharmaceutical enterprise with branch offices and partners in Europe and the USA. We are developers and producers of a new product line of diagnostic tools based on a new and innovative bio-marker. The potential of our products will change and improve the medical diagnosis.
With the help of our new products, not only are we capable of diagnosing a myocardial infarction - also known as ACS (Acute Coronary Syndrome) - quicker and more accurately, but also can we perform faster, safer and more effectively.
The health system can also benefit from it, as cost-effectiveness can be increased by getting earlier and more precise resources and by reducing the frequency of misdiagnosis.
Ernest Kapetanovic, CEO & Founder
Sam Yastas, COO & Co-Founder
Hermann Josef Ernst, Board Member
Scientific Advisory Board
Prof. Dr. med. Reiner Körfer
Prof. Dr. med. Siegfried Seeber
Prof. Dr. med. Louise Kenny
Prof. Dr. med. Mario Dicato
Prof. Dr. Pierre Khuri Yakub
Dr. Aaron Kugelmass
Business Advisory Board
Prof. Dr. Dr. Ralf U. Peter KCR
Karl-Peter von Habsburg
Prof. Manfred Maus
Dr. Michael Silverman